1. Jobe, A.H. Animal models, learning lessons to prevent and treat neonatal chronic lung disease. Front. Med. 2015, 2, 1–13, doi:10.3389/fmed.2015.00049.
2. Martin, J.A.; Osterman, M.J.K. Describing the Increase in Preterm Births in the United States, 2014-2016 Key findings Data from the National Vital Statistics System. NCHS Data Brief 2018, 312, 1–29.
3. Wadhawan, R.; Vohr, B.R.; Fanaroff, A.A.; Perritt, R.L.; Duara, S.; Stoll, B.J.; Goldberg, R.; Laptook, A.; Poole, K.; Wright, L.L.; et al. Does labor influence neonatal and neurodevelopmental outcomes of extremely-low-birth-weight infants who are born by cesarean delivery? Am. J. Obstet. Gynecol. 2003, 189, 501–506, doi:10.1067/S0002-9378(03)00360-0.
4. Stoll B.J., Hansen N.I., Bell E.F., et al. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010, 126(3):443-456.
5. Charafeddine, Lama, et al. Atypical Chronic Lung Disease Patterns in Neonates. Pediatrics 1999, 103, 759–765.
6. Lavoie, P.M.; Pham, C.; Jang, K.L. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 2008, 122, 479–485, doi:10.1542/peds.2007-2313.
7. Pasha, A.B.; Chen, X.Q.; Zhou, G.P. Bronchopulmonary dysplasia: Pathogenesis and treatment (review). Exp. Ther. Med. 2018, 16, 4315–4321, doi:10.3892/etm.2018.6780.
8. Watts, C. L., and A.A.F. Fibronectin: Role in Respiratory Distress Syndrome and Bronchopulmonary Dysplasia. Semin. Perinatol. 1992, 16, 162–169.
9. Henderson, B.; Nair, S.; Pallas, J.; Williams, M.A. Fibronectin: A multidomain host adhesin targeted by bacterial fibronectin-binding proteins. FEMS Microbiol. Rev. 2011, 35, 147–200, doi:10.1111/j.1574-6976.2010.00243.x.
10. Clemmensen I. Fibronectin and its role in connective tissue diseases. Eur J Clin Invest. 1981, 11(3), 145–6.
11. Hynes, R.O. Fibronectins.
12. Fischer, H.S.; Schmölzer, G.M.; Cheung, P.Y.; Bührer, C. Sustained inflations and avoiding mechanical ventilation to prevent death or bronchopulmonary dysplasia: A meta-analysis. Eur. Respir. Rev. 2018, 27, doi:10.1183/16000617.0083-2018.
13. Isayama, T.; Lee, S.K.; Yang, J.; Lee, D.; Daspal, S.; Dunn, M.; Shah, P.S. Revisiting the Definition of Bronchopulmonary Dysplasia. JAMA Pediatr. 2017, 171, 271, doi:10.1001/jamapediatrics.2016.4141.
14. Avila, J.J.; Lympany, P.A.; Pantelidis, P.; Welsh, K.I.; Black, C.M.; Du Bois, R.M. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am. J. Respir. Cell Mol. Biol. 1999, 20, 106–112, doi:10.1165/ajrcmb.20.1.3232.
15. Murat, M.; Aekeper, A.; Yuan, L.Y.; Alim, T.; Du, G.J.; Abdusamat, A.; Wu, G.W.; Aniwer, Y. Correlation between the development of calcium oxalate stones and polymorphisms in the fibronectin gene in the Uighur population of the Xinjiang region of China. Genet. Mol. Res. 2015, 14, 13728–13734, doi:10.4238/2015.October.28.35.
16. Natarajan, G.; Shankaran, S. Short- and Long-Term Outcomes of Moderate and Late Preterm Infants. Am. J. Perinatol. 2016, 33, 305–17, doi:10.1055/s-0035-1571150.
17. Thébaud, B.; Goss, K.N.; Laughon, M.; Whitsett, J.A.; Abman, S.H.; Steinhorn, R.H.; Aschner, J.L.; Davis, P.G.; McGrath-Morrow, S.A.; Soll, R.F.; et al. Bronchopulmonary dysplasia. Nat. Rev. Dis. Prim. 2019, 5, doi:10.1038/s41572-019-0127-7.
18. Mao, Y.; Schwarzbauer, J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005, 24, 389–399, doi:10.1016/j.matbio.2005.06.008.
19. Sinkin, R.A.; Roberts, M.; LoMonaco, M.B.; Sanders, R.J.; Metlay, L.A. Fibronectin Expression in Bronchopulmonary Dysplasia. Pediatr. Dev. Pathol. 1998, 1, 494–502, doi:10.1007/s100249900068.
20. Mižíková, I.; Morty, R.E. The Extracellular Matrix in Bronchopulmonary Dysplasia: Target and Source. Front. Med. 2015, 2, doi:10.3389/fmed.2015.00091.
21. Duan, J.; Zhang, X.; Zhang, S.; Hua, S.; Feng, Z. MiR-206 inhibits FN1 expression and proliferation and promotes apoptosis of rat type II alveolar epithelial cells. Exp. Ther. Med. 2017, 13, 3203–3208, doi:10.3892/etm.2017.4430.
22. de Vasconcellos, J.F.; Jackson, W.M.; Dimtchev, A.; Nesti, L.J. A microRNA Signature for Impaired Wound-Healing and Ectopic Bone Formation in Humans. J. Bone Joint Surg. Am. 2020, 102, 1891–1899, doi:10.2106/JBJS.19.00896.
23. Kallapur, S.G.; Pryhuber, G.S. Bronchopulmonary Dysplasia—The Search for Answers Continues. Clin. Perinatol. 2015, 42, xix–xx, doi:10.1016/j.clp.2015.09.001.
24. Onaran, M.; Yilmaz, A.; Şen, I.; Ergun, M.A.; Çamtosun, A.; Küpeli, B.; Menevşe, S.; Bozkirli, I. A HindIII Polymorphism of Fibronectin Gene Is Associated With Nephrolithiasis. Urology 2009, 74, 1004–1007, doi:10.1016/j.urology.2009.05.010.
25. Lee, C.S.; Fu, H.; Baratang, N.; Rousseau, J.; Kumra, H.; Sutton, V.R.; Niceta, M.; Ciolfi, A.; Yamamoto, G.; Bertola, D.; et al. Mutations in Fibronectin Cause a Subtype of Spondylometaphyseal Dysplasia with “Corner Fractures.” Am. J. Hum. Genet. 2017, 101, 815–823, doi:10.1016/j.ajhg.2017.09.019.
26. Yang, H.Y.; Su, S.L.; Peng, Y.J.; Wang, C.C.; Lee, H.S.; Salter, D.M.; Lee, C.H. An intron polymorphism of the fibronectin gene is associated with end-stage knee osteoarthritis in a Han Chinese population: Two independent case - Control studies. BMC Musculoskelet. Disord. 2014, 15, 1–9, doi:10.1186/1471-2474-15-173.
27. Qin, S.; Zhang, B.; Xiao, G.; Sun, X.; Li, G.; Huang, G.; Gao, X.; Li, X.; Wang, H.; Yang, C.; et al. Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation. Tumor Biol. 2016, 37, 13509–13520, doi:10.1007/s13277-016-5206-8.
28. Siemianowicz, K.; Gminski, J.; Francuz, T.; Syzdol, M.; Polanska, D.; Machalski, M.; Brulinski, K.; Magiera-Molendowska, H. Fibronectin gene polymorphism in patients with lung cancer. Oncol. Rep. 2001, doi:10.3892/or.8.6.1289.
29. Sun, Y.; Ye, Y.; Wang, Z.; He, Y.; Li, Y.; Mao, H.; Zhao, C. High expression of fibronectin 1 indicates poor prognosis in gastric cancer. Oncol. Lett. 2020, 19, 93–102, doi:10.3892/ol.2019.11088.
30. Libring, S.; Shinde, A.; Chanda, M.K.; Nuru, M.; George, H.; Saleh, A.M.; Abdullah, A.; Kinzer-Ursem, T.L.; Calve, S.; Wendt, M.K.; et al. The dynamic relationship of breast cancer cells and fibroblasts in fibronectin accumulation at primary and metastatic tumor sites. Cancers (Basel). 2020, 12, doi:10.3390/cancers12051270.
31. Nakata, K.; Ujike, H.; Sakai, A.; Takaki, M.; Imamura, T.; Tanaka, Y.; Kuroda, S. Association study between the fibronectin gene and schizophrenia. Am. J. Med. Genet. - Neuropsychiatr. Genet. 2003, 116 B, 41–44, doi:10.1002/ajmg.b.10796.
32. Szpecht, D.; Al-Saad, S.R.; Karbowski, L.M.; Kosik, K.; Kurzawińska, G.; Szymankiewicz, M.; Drews, K.; Seremak-Mrozikiewicz, A. Role of Fibronectin-1 polymorphism genes with the pathogenesis of intraventricular hemorrhage in preterm infants. Child’s Nerv. Syst. 2020, 36, 1729–1736, doi:10.1007/s00381-020-04598-3.
33. Ballabh, P. Pathogenesis and Prevention of Intraventricular Hemorrhage. Clin. Perinatol. 2014, 41, 47–67, doi:10.1016/j.clp.2013.09.007.
34. Tilling, T.; Engelbertz, C.; Decker, S.; Korte, D.; Hüwel, S.; Galla, H.J. Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures. Cell Tissue Res. 2002, 310, 19–29, doi:10.1007/s00441-002-0604-1.
35. Hallmann, R.; Horn, N.; Selg, M.; Wendler, O.; Pausch, F.; Sorokin, L.M. Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 2005, 85, 979–1000, doi:10.1152/physrev.00014.2004.
36. Raets, M.M.A.; Dudink, J.; Govaert, P. Neonatal disorders of germinal matrix. J. Matern. Neonatal Med. 2015, 28, 2286–2290, doi:10.3109/14767058.2013.796169.
37. Xu, H.; Hu, F.; Sado, Y.; Ninomiya, Y.; Borza, D.B.; Ungvari, Z.; LaGamma, E.F.; Csiszar, A.; Nedergaard, M.; Ballabh, P. Maturational changes in laminin, fibronectin, collagen IV, and perlecan in germinal matrix, cortex, and white matter and effect of betamethasone. J. Neurosci. Res. 2008, 86, 1482–1500, doi:10.1002/jnr.21618.
38. Ballabh, P. Intraventricular hemorrhage in premature infants: Mechanism of disease. Pediatr. Res. 2010, 67, 1–8, doi:10.1203/PDR.0b013e3181c1b176.
39. Rezvani, M.; Wilde, J.; Vitt, P.; Mailaparambil, B.; Grychtol, R.; Krueger, M.; Heinzmann, A. Association of a FGFR-4 gene polymorphism with bronchopulmonary dysplasia and neonatal respiratory distress. Dis. Markers 2013, 35, 633–640, doi:10.1155/2013/932356.
40. Floros, J.; Londono, D.; Gordon, D.; Silveyra, P.; Diangelo, S.L.; Viscardi, R.M.; Worthen, G.S.; Shenberger, J.; Wang, G.; Lin, Z.; et al. IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants. Pediatr. Res. 2012, 71, 107–114, doi:10.1038/pr.2011.14.
41. Winters, A.H.; LeVan, T.D.; Vogel, S.N.; Chesko, K.L.; Pollin, T.I.; Viscardi, R.M. Single Nucleotide Polymorphism in Toll-like Receptor 6 Is Associated With a Decreased Risk for Ureaplasma Respiratory Tract Colonization and Bronchopulmonary Dysplasia in Preterm Infants. Pediatr. Infect. Dis. J. 2013, 32, 898–904, doi:10.1097/INF.0b013e31828fc693.